Summary
Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
According to APO Research, The global Clinical Trial Imaging market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Clinical Trial Imaging is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Clinical Trial Imaging is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Clinical Trial Imaging is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Clinical Trial Imaging is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Clinical Trial Imaging include ICON, ERT, McLaren, Bioclinica, Parexel, BioTelemetry, ProScan Imaging, Imaging Endpoints and Radiant Sage, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Clinical Trial Imaging, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Clinical Trial Imaging, also provides the revenue of main regions and countries. Of the upcoming market potential for Clinical Trial Imaging, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Clinical Trial Imaging revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Clinical Trial Imaging market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Clinical Trial Imaging revenue, projected growth trends, production technology, application and end-user industry.
Clinical Trial Imaging segment by Company
ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Clinical Trial Imaging segment by Type
In-house Imaging Service
Central Imaging Service
Clinical Trial Imaging segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others
Clinical Trial Imaging segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trial Imaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clinical Trial Imaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trial Imaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Clinical Trial Imaging in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Clinical Trial Imaging company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Trial Imaging revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Clinical Trial Imaging Market by Type
1.2.1 Global Clinical Trial Imaging Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 In-house Imaging Service
1.2.3 Central Imaging Service
1.3 Clinical Trial Imaging Market by Application
1.3.1 Global Clinical Trial Imaging Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Biotechnology Companies
1.3.4 Academic Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Clinical Trial Imaging Market Dynamics
2.1 Clinical Trial Imaging Industry Trends
2.2 Clinical Trial Imaging Industry Drivers
2.3 Clinical Trial Imaging Industry Opportunities and Challenges
2.4 Clinical Trial Imaging Industry Restraints
3 Global Growth Perspective
3.1 Global Clinical Trial Imaging Market Perspective (2019-2030)
3.2 Global Clinical Trial Imaging Growth Trends by Region
3.2.1 Global Clinical Trial Imaging Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Clinical Trial Imaging Market Size by Region (2019-2024)
3.2.3 Global Clinical Trial Imaging Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Clinical Trial Imaging Revenue by Players
4.1.1 Global Clinical Trial Imaging Revenue by Players (2019-2024)
4.1.2 Global Clinical Trial Imaging Revenue Market Share by Players (2019-2024)
4.1.3 Global Clinical Trial Imaging Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Clinical Trial Imaging Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Clinical Trial Imaging Key Players Headquarters & Area Served
4.4 Global Clinical Trial Imaging Players, Product Type & Application
4.5 Global Clinical Trial Imaging Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Clinical Trial Imaging Market CR5 and HHI
4.6.2 Global Top 5 and 10 Clinical Trial Imaging Players Market Share by Revenue in 2023
4.6.3 2023 Clinical Trial Imaging Tier 1, Tier 2, and Tier 3
5 Clinical Trial Imaging Market Size by Type
5.1 Global Clinical Trial Imaging Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Clinical Trial Imaging Revenue by Type (2019-2030)
5.3 Global Clinical Trial Imaging Revenue Market Share by Type (2019-2030)
6 Clinical Trial Imaging Market Size by Application
6.1 Global Clinical Trial Imaging Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Clinical Trial Imaging Revenue by Application (2019-2030)
6.3 Global Clinical Trial Imaging Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 ICON
7.1.1 ICON Comapny Information
7.1.2 ICON Business Overview
7.1.3 ICON Clinical Trial Imaging Revenue and Gross Margin (2019-2024)
7.1.4 ICON Clinical Trial Imaging Product Portfolio
7.1.5 ICON Recent Developments
7.2 ERT
7.2.1 ERT Comapny Information
7.2.2 ERT Business Overview
7.2.3 ERT Clinical Trial Imaging Revenue and Gross Margin (2019-2024)
7.2.4 ERT Clinical Trial Imaging Product Portfolio
7.2.5 ERT Recent Developments
7.3 McLaren
7.3.1 McLaren Comapny Information
7.3.2 McLaren Business Overview
7.3.3 McLaren Clinical Trial Imaging Revenue and Gross Margin (2019-2024)
7.3.4 McLaren Clinical Trial Imaging Product Portfolio
7.3.5 McLaren Recent Developments
7.4 Bioclinica
7.4.1 Bioclinica Comapny Information
7.4.2 Bioclinica Business Overview
7.4.3 Bioclinica Clinical Trial Imaging Revenue and Gross Margin (2019-2024)
7.4.4 Bioclinica Clinical Trial Imaging Product Portfolio
7.4.5 Bioclinica Recent Developments
7.5 Parexel
7.5.1 Parexel Comapny Information
7.5.2 Parexel Business Overview
7.5.3 Parexel Clinical Trial Imaging Revenue and Gross Margin (2019-2024)
7.5.4 Parexel Clinical Trial Imaging Product Portfolio
7.5.5 Parexel Recent Developments
7.6 BioTelemetry
7.6.1 BioTelemetry Comapny Information
7.6.2 BioTelemetry Business Overview
7.6.3 BioTelemetry Clinical Trial Imaging Revenue and Gross Margin (2019-2024)
7.6.4 BioTelemetry Clinical Trial Imaging Product Portfolio
7.6.5 BioTelemetry Recent Developments
7.7 ProScan Imaging
7.7.1 ProScan Imaging Comapny Information
7.7.2 ProScan Imaging Business Overview
7.7.3 ProScan Imaging Clinical Trial Imaging Revenue and Gross Margin (2019-2024)
7.7.4 ProScan Imaging Clinical Trial Imaging Product Portfolio
7.7.5 ProScan Imaging Recent Developments
7.8 Imaging Endpoints
7.8.1 Imaging Endpoints Comapny Information
7.8.2 Imaging Endpoints Business Overview
7.8.3 Imaging Endpoints Clinical Trial Imaging Revenue and Gross Margin (2019-2024)
7.8.4 Imaging Endpoints Clinical Trial Imaging Product Portfolio
7.8.5 Imaging Endpoints Recent Developments
7.9 Radiant Sage
7.9.1 Radiant Sage Comapny Information
7.9.2 Radiant Sage Business Overview
7.9.3 Radiant Sage Clinical Trial Imaging Revenue and Gross Margin (2019-2024)
7.9.4 Radiant Sage Clinical Trial Imaging Product Portfolio
7.9.5 Radiant Sage Recent Developments
7.10 Micron, Inc.
7.10.1 Micron, Inc. Comapny Information
7.10.2 Micron, Inc. Business Overview
7.10.3 Micron, Inc. Clinical Trial Imaging Revenue and Gross Margin (2019-2024)
7.10.4 Micron, Inc. Clinical Trial Imaging Product Portfolio
7.10.5 Micron, Inc. Recent Developments
7.11 Intrinsic Imaging
7.11.1 Intrinsic Imaging Comapny Information
7.11.2 Intrinsic Imaging Business Overview
7.11.3 Intrinsic Imaging Clinical Trial Imaging Revenue and Gross Margin (2019-2024)
7.11.4 Intrinsic Imaging Clinical Trial Imaging Product Portfolio
7.11.5 Intrinsic Imaging Recent Developments
7.12 Median Technologies
7.12.1 Median Technologies Comapny Information
7.12.2 Median Technologies Business Overview
7.12.3 Median Technologies Clinical Trial Imaging Revenue and Gross Margin (2019-2024)
7.12.4 Median Technologies Clinical Trial Imaging Product Portfolio
7.12.5 Median Technologies Recent Developments
7.13 Cardiovascular Imaging Technologies
7.13.1 Cardiovascular Imaging Technologies Comapny Information
7.13.2 Cardiovascular Imaging Technologies Business Overview
7.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue and Gross Margin (2019-2024)
7.13.4 Cardiovascular Imaging Technologies Clinical Trial Imaging Product Portfolio
7.13.5 Cardiovascular Imaging Technologies Recent Developments
7.14 Banook Medical
7.14.1 Banook Medical Comapny Information
7.14.2 Banook Medical Business Overview
7.14.3 Banook Medical Clinical Trial Imaging Revenue and Gross Margin (2019-2024)
7.14.4 Banook Medical Clinical Trial Imaging Product Portfolio
7.14.5 Banook Medical Recent Developments
7.15 IXICO
7.15.1 IXICO Comapny Information
7.15.2 IXICO Business Overview
7.15.3 IXICO Clinical Trial Imaging Revenue and Gross Margin (2019-2024)
7.15.4 IXICO Clinical Trial Imaging Product Portfolio
7.15.5 IXICO Recent Developments
8 North America
8.1 North America Clinical Trial Imaging Revenue (2019-2030)
8.2 North America Clinical Trial Imaging Revenue by Type (2019-2030)
8.2.1 North America Clinical Trial Imaging Revenue by Type (2019-2024)
8.2.2 North America Clinical Trial Imaging Revenue by Type (2025-2030)
8.3 North America Clinical Trial Imaging Revenue Share by Type (2019-2030)
8.4 North America Clinical Trial Imaging Revenue by Application (2019-2030)
8.4.1 North America Clinical Trial Imaging Revenue by Application (2019-2024)
8.4.2 North America Clinical Trial Imaging Revenue by Application (2025-2030)
8.5 North America Clinical Trial Imaging Revenue Share by Application (2019-2030)
8.6 North America Clinical Trial Imaging Revenue by Country
8.6.1 North America Clinical Trial Imaging Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Clinical Trial Imaging Revenue by Country (2019-2024)
8.6.3 North America Clinical Trial Imaging Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Clinical Trial Imaging Revenue (2019-2030)
9.2 Europe Clinical Trial Imaging Revenue by Type (2019-2030)
9.2.1 Europe Clinical Trial Imaging Revenue by Type (2019-2024)
9.2.2 Europe Clinical Trial Imaging Revenue by Type (2025-2030)
9.3 Europe Clinical Trial Imaging Revenue Share by Type (2019-2030)
9.4 Europe Clinical Trial Imaging Revenue by Application (2019-2030)
9.4.1 Europe Clinical Trial Imaging Revenue by Application (2019-2024)
9.4.2 Europe Clinical Trial Imaging Revenue by Application (2025-2030)
9.5 Europe Clinical Trial Imaging Revenue Share by Application (2019-2030)
9.6 Europe Clinical Trial Imaging Revenue by Country
9.6.1 Europe Clinical Trial Imaging Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Clinical Trial Imaging Revenue by Country (2019-2024)
9.6.3 Europe Clinical Trial Imaging Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Clinical Trial Imaging Revenue (2019-2030)
10.2 China Clinical Trial Imaging Revenue by Type (2019-2030)
10.2.1 China Clinical Trial Imaging Revenue by Type (2019-2024)
10.2.2 China Clinical Trial Imaging Revenue by Type (2025-2030)
10.3 China Clinical Trial Imaging Revenue Share by Type (2019-2030)
10.4 China Clinical Trial Imaging Revenue by Application (2019-2030)
10.4.1 China Clinical Trial Imaging Revenue by Application (2019-2024)
10.4.2 China Clinical Trial Imaging Revenue by Application (2025-2030)
10.5 China Clinical Trial Imaging Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Clinical Trial Imaging Revenue (2019-2030)
11.2 Asia Clinical Trial Imaging Revenue by Type (2019-2030)
11.2.1 Asia Clinical Trial Imaging Revenue by Type (2019-2024)
11.2.2 Asia Clinical Trial Imaging Revenue by Type (2025-2030)
11.3 Asia Clinical Trial Imaging Revenue Share by Type (2019-2030)
11.4 Asia Clinical Trial Imaging Revenue by Application (2019-2030)
11.4.1 Asia Clinical Trial Imaging Revenue by Application (2019-2024)
11.4.2 Asia Clinical Trial Imaging Revenue by Application (2025-2030)
11.5 Asia Clinical Trial Imaging Revenue Share by Application (2019-2030)
11.6 Asia Clinical Trial Imaging Revenue by Country
11.6.1 Asia Clinical Trial Imaging Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Clinical Trial Imaging Revenue by Country (2019-2024)
11.6.3 Asia Clinical Trial Imaging Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Clinical Trial Imaging Revenue (2019-2030)
12.2 MEALA Clinical Trial Imaging Revenue by Type (2019-2030)
12.2.1 MEALA Clinical Trial Imaging Revenue by Type (2019-2024)
12.2.2 MEALA Clinical Trial Imaging Revenue by Type (2025-2030)
12.3 MEALA Clinical Trial Imaging Revenue Share by Type (2019-2030)
12.4 MEALA Clinical Trial Imaging Revenue by Application (2019-2030)
12.4.1 MEALA Clinical Trial Imaging Revenue by Application (2019-2024)
12.4.2 MEALA Clinical Trial Imaging Revenue by Application (2025-2030)
12.5 MEALA Clinical Trial Imaging Revenue Share by Application (2019-2030)
12.6 MEALA Clinical Trial Imaging Revenue by Country
12.6.1 MEALA Clinical Trial Imaging Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Clinical Trial Imaging Revenue by Country (2019-2024)
12.6.3 MEALA Clinical Trial Imaging Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Clinical Trial Imaging Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. In-house Imaging Service Major Manufacturers
Table 2. Central Imaging Service Major Manufacturers
Table 3. Global Clinical Trial Imaging Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 4. Pharmaceutical Companies Major Manufacturers
Table 5. Biotechnology Companies Major Manufacturers
Table 6. Academic Institutes Major Manufacturers
Table 7. Others Major Manufacturers
Table 8. Clinical Trial Imaging Industry Trends
Table 9. Clinical Trial Imaging Industry Drivers
Table 10. Clinical Trial Imaging Industry Opportunities and Challenges
Table 11. Clinical Trial Imaging Industry Restraints
Table 12. Global Clinical Trial Imaging Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 13. Global Clinical Trial Imaging Market Size by Region (2019-2024) & (US$ Million)
Table 14. Global Clinical Trial Imaging Market Share by Region (2019-2024)
Table 15. Global Clinical Trial Imaging Market Size by Region (2025-2030) & (US$ Million)
Table 16. Global Clinical Trial Imaging Market Share by Region (2025-2030)
Table 17. Global Clinical Trial Imaging Revenue by Players (US$ Million) & (2019-2024)
Table 18. Global Clinical Trial Imaging Revenue Market Share by Players (2019-2024)
Table 19. Global Clinical Trial Imaging Key Players Ranking, 2022 VS 2023 VS 2024
Table 20. Global Clinical Trial Imaging Key Players Headquarters & Area Served
Table 21. Global Clinical Trial Imaging Players, Product Type & Application
Table 22. Global Clinical Trial Imaging Players Commercialization Time
Table 23. Global Players Market Concentration Ratio (CR5 and HHI)
Table 24. Global Clinical Trial Imaging by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 25. Global Clinical Trial Imaging Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 26. Global Clinical Trial Imaging Revenue by Type (2019-2024) & (US$ Million)
Table 27. Global Clinical Trial Imaging Revenue by Type (2025-2030) & (US$ Million)
Table 28. Global Clinical Trial Imaging Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 29. Global Clinical Trial Imaging Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 30. Global Clinical Trial Imaging Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Global Clinical Trial Imaging Revenue by Application (2019-2024) & (US$ Million)
Table 32. Global Clinical Trial Imaging Revenue by Application (2025-2030) & (US$ Million)
Table 33. Global Clinical Trial Imaging Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 34. Global Clinical Trial Imaging Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 35. ICON Company Information
Table 36. ICON Business Overview
Table 37. ICON Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 38. ICON Clinical Trial Imaging Product Portfolio
Table 39. ICON Recent Development
Table 40. ERT Company Information
Table 41. ERT Business Overview
Table 42. ERT Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 43. ERT Clinical Trial Imaging Product Portfolio
Table 44. ERT Recent Development
Table 45. McLaren Company Information
Table 46. McLaren Business Overview
Table 47. McLaren Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 48. McLaren Clinical Trial Imaging Product Portfolio
Table 49. McLaren Recent Development
Table 50. Bioclinica Company Information
Table 51. Bioclinica Business Overview
Table 52. Bioclinica Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 53. Bioclinica Clinical Trial Imaging Product Portfolio
Table 54. Bioclinica Recent Development
Table 55. Parexel Company Information
Table 56. Parexel Business Overview
Table 57. Parexel Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 58. Parexel Clinical Trial Imaging Product Portfolio
Table 59. Parexel Recent Development
Table 60. BioTelemetry Company Information
Table 61. BioTelemetry Business Overview
Table 62. BioTelemetry Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 63. BioTelemetry Clinical Trial Imaging Product Portfolio
Table 64. BioTelemetry Recent Development
Table 65. ProScan Imaging Company Information
Table 66. ProScan Imaging Business Overview
Table 67. ProScan Imaging Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 68. ProScan Imaging Clinical Trial Imaging Product Portfolio
Table 69. ProScan Imaging Recent Development
Table 70. Imaging Endpoints Company Information
Table 71. Imaging Endpoints Business Overview
Table 72. Imaging Endpoints Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 73. Imaging Endpoints Clinical Trial Imaging Product Portfolio
Table 74. Imaging Endpoints Recent Development
Table 75. Radiant Sage Company Information
Table 76. Radiant Sage Business Overview
Table 77. Radiant Sage Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 78. Radiant Sage Clinical Trial Imaging Product Portfolio
Table 79. Radiant Sage Recent Development
Table 80. Micron, Inc. Company Information
Table 81. Micron, Inc. Business Overview
Table 82. Micron, Inc. Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 83. Micron, Inc. Clinical Trial Imaging Product Portfolio
Table 84. Micron, Inc. Recent Development
Table 85. Intrinsic Imaging Company Information
Table 86. Intrinsic Imaging Business Overview
Table 87. Intrinsic Imaging Clinical Trial Imaging Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2019-2024)
Table 88. Intrinsic Imaging Clinical Trial Imaging Product Portfolio
Table 89. Intrinsic Imaging Recent Development
Table 90. Median Technologies Company Information
Table 91. Median Technologies Business Overview
Table 92. Median Technologies Clinical Trial Imaging Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2019-2024)
Table 93. Median Technologies Clinical Trial Imaging Product Portfolio
Table 94. Median Technologies Recent Development
Table 95. Cardiovascular Imaging Technologies Company Information
Table 96. Cardiovascular Imaging Technologies Business Overview
Table 97. Cardiovascular Imaging Technologies Clinical Trial Imaging Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2019-2024)
Table 98. Cardiovascular Imaging Technologies Clinical Trial Imaging Product Portfolio
Table 99. Cardiovascular Imaging Technologies Recent Development
Table 100. Banook Medical Company Information
Table 101. Banook Medical Business Overview
Table 102. Banook Medical Clinical Trial Imaging Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2019-2024)
Table 103. Banook Medical Clinical Trial Imaging Product Portfolio
Table 104. Banook Medical Recent Development
Table 105. IXICO Company Information
Table 106. IXICO Business Overview
Table 107. IXICO Clinical Trial Imaging Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2019-2024)
Table 108. IXICO Clinical Trial Imaging Product Portfolio
Table 109. IXICO Recent Development
Table 110. North America Clinical Trial Imaging Revenue by Type (2019-2024) & (US$ Million)
Table 111. North America Clinical Trial Imaging Revenue by Application (2019-2024) & (US$ Million)
Table 112. North America Clinical Trial Imaging Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 113. North America Clinical Trial Imaging Revenue by Country (2019-2024) & (US$ Million)
Table 114. North America Clinical Trial Imaging Revenue by Country (2025-2030) & (US$ Million)
Table 115. Europe Clinical Trial Imaging Revenue by Type (2019-2024) & (US$ Million)
Table 116. Europe Clinical Trial Imaging Revenue by Application (2019-2024) & (US$ Million)
Table 117. Europe Clinical Trial Imaging Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 118. Europe Clinical Trial Imaging Revenue by Country (2019-2024) & (US$ Million)
Table 119. Europe Clinical Trial Imaging Revenue by Country (2025-2030) & (US$ Million)
Table 120. China Clinical Trial Imaging Revenue by Type (2019-2024) & (US$ Million)
Table 121. China Clinical Trial Imaging Revenue by Application (2019-2024) & (US$ Million)
Table 122. Asia Clinical Trial Imaging Revenue by Type (2019-2024) & (US$ Million)
Table 123. Asia Clinical Trial Imaging Revenue by Application (2019-2024) & (US$ Million)
Table 124. Asia Clinical Trial Imaging Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 125. Asia Clinical Trial Imaging Revenue by Country (2019-2024) & (US$ Million)
Table 126. Asia Clinical Trial Imaging Revenue by Country (2025-2030) & (US$ Million)
Table 127. MEALA Clinical Trial Imaging Revenue by Type (2019-2024) & (US$ Million)
Table 128. MEALA Clinical Trial Imaging Revenue by Application (2019-2024) & (US$ Million)
Table 129. MEALA Clinical Trial Imaging Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 130. MEALA Clinical Trial Imaging Revenue by Country (2019-2024) & (US$ Million)
Table 131. MEALA Clinical Trial Imaging Revenue by Country (2025-2030) & (US$ Million)
Table 132. Research Programs/Design for This Report
Table 133. Authors List of This Report
Table 134. Secondary Sources
Table 135. Primary Sources
List of Figures
Figure 1. Clinical Trial Imaging Product Picture
Figure 2. Global Clinical Trial Imaging Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Clinical Trial Imaging Market Size Share 2019 VS 2023 VS 2030
Figure 4. In-house Imaging Service Picture
Figure 5. Central Imaging Service Picture
Figure 6. Global Clinical Trial Imaging Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Clinical Trial Imaging Market Size Share 2019 VS 2023 VS 2030
Figure 8. Pharmaceutical Companies Picture
Figure 9. Biotechnology Companies Picture
Figure 10. Academic Institutes Picture
Figure 11. Others Picture
Figure 12. Global Clinical Trial Imaging Market Size (US$ Million) & (2019-2030)
Figure 13. Global Clinical Trial Imaging Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Clinical Trial Imaging Market Share by Region: 2019 VS 2023 VS 2030
Figure 15. Global Clinical Trial Imaging Players Revenue Share Top 10 and Top 5 in 2023
Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 17. Global Clinical Trial Imaging Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Clinical Trial Imaging Revenue Market Share 2019 VS 2023 VS 2030
Figure 19. Global Clinical Trial Imaging Revenue Market Share by Type (2019-2030)
Figure 20. Global Clinical Trial Imaging Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Clinical Trial Imaging Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 22. Global Clinical Trial Imaging Revenue Market Share by Application (2019-2030)
Figure 23. North America Clinical Trial Imaging Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Clinical Trial Imaging Revenue by Type (2025-2030) & (US$ Million)
Figure 25. North America Clinical Trial Imaging Revenue Share by Type (2019-2030)
Figure 26. North America Clinical Trial Imaging Revenue by Application (2025-2030) & (US$ Million)
Figure 27. North America Clinical Trial Imaging Revenue Share by Application (2019-2030)
Figure 28. North America Clinical Trial Imaging Revenue Share by Country (2019-2030)
Figure 29. United States Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 30. Canada Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 31. Europe Clinical Trial Imaging Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 32. Europe Clinical Trial Imaging Revenue by Type (2025-2030) & (US$ Million)
Figure 33. Europe Clinical Trial Imaging Revenue Share by Type (2019-2030)
Figure 34. Europe Clinical Trial Imaging Revenue by Application (2025-2030) & (US$ Million)
Figure 35. Europe Clinical Trial Imaging Revenue Share by Application (2019-2030)
Figure 36. Europe Clinical Trial Imaging Revenue Share by Country (2019-2030)
Figure 37. Germany Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. France Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. U.K. Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Italy Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Russia Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Nordic Countries Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. China Clinical Trial Imaging Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Clinical Trial Imaging Revenue by Type (2025-2030) & (US$ Million)
Figure 45. China Clinical Trial Imaging Revenue Share by Type (2019-2030)
Figure 46. China Clinical Trial Imaging Revenue by Application (2025-2030) & (US$ Million)
Figure 47. China Clinical Trial Imaging Revenue Share by Application (2019-2030)
Figure 48. Asia Clinical Trial Imaging Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 49. Asia Clinical Trial Imaging Revenue by Type (2025-2030) & (US$ Million)
Figure 50. Asia Clinical Trial Imaging Revenue Share by Type (2019-2030)
Figure 51. Asia Clinical Trial Imaging Revenue by Application (2025-2030) & (US$ Million)
Figure 52. Asia Clinical Trial Imaging Revenue Share by Application (2019-2030)
Figure 53. Asia Clinical Trial Imaging Revenue Share by Country (2019-2030)
Figure 54. Japan Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. South Korea Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. India Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. Australia Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. China Taiwan Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. Southeast Asia Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. MEALA Clinical Trial Imaging Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 61. MEALA Clinical Trial Imaging Revenue by Type (2025-2030) & (US$ Million)
Figure 62. MEALA Clinical Trial Imaging Revenue Share by Type (2019-2030)
Figure 63. MEALA Clinical Trial Imaging Revenue by Application (2025-2030) & (US$ Million)
Figure 64. MEALA Clinical Trial Imaging Revenue Share by Application (2019-2030)
Figure 65. MEALA Clinical Trial Imaging Revenue Share by Country (2019-2030)
Figure 66. Mexico Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. South Korea Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Brazil Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Israel Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Argentina Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Colombia Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Turkey Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Saudi Arabia Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. UAE Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. Years Considered
Figure 76. Research Process
Figure 77. Key Executives Interviewed
